Biotech
AstraZeneca's New Cancer Drug Offers Hope
AstraZeneca invested billions into a new drug that could change how doctors fight cancer, according to its CEO.
AstraZeneca CEO Pascal Soriot shared big news from Cambridge, Massachusetts. He talked about a new drug called Summit. This drug could help doctors create better ways to treat cancer in the future.
AstraZeneca made a large investment in this new drug. The company spent $2 billion to help make Summit a reality. This shows how much they believe in its power.
Soriot spoke from AstraZeneca's new $1 billion research building. The company hopes this new drug will lead to powerful new drug mixes. These mixes could help many people battling cancer.
Source: CNBC
#Biotech#AstraZeneca#Cancer Treatment#Drug Development
More from Biotech
